Intensive blood sugar treatment in trial of diabetes and cardiovascular disea...(vents such as heart attack stroke or dea...),Health

Date:2/6/2008

vents such as heart attack, stroke, or death from cardiovascular disease, specifically in people with type 2 diabetes who are at particularly high risk for a cardiovascular event. Prior studies suggested that reducing blood sugar to levels found in non-diabetic adults may reduce the rate of cardiovascular diseases among those with diabetes. However, a randomized clinical trial was needed to determine whether that hypothesis is accurate.

ACCORD is an important study intended to find new answers to help people with type 2 diabetes reduce their high risk of heart disease, said Denise G. Simons-Morton, M.D., Ph.D., NHLBI project officer for ACCORD and a member of the ACCORD steering committee. Hypotheses about treatments to prevent cardiovascular disease in people with type 2 diabetes need to be tested in clinical trials such as ACCORD. The ACCORD results, along with results from other studies, will contribute to determining what the treatment goals should be in patients with various characteristics.

Conducted at 77 sites nationwide and in Canada, the trial includes adults between the ages of 40 and 82 at enrollment who, in addition to type 2 diabetes, also have two or more other risk factors for heart disease or had been diagnosed with heart disease before entering the study. Thus, participants were included in the ACCORD trial because they were at especially high riskmore risk than is associated with diabetes alonefor having a heart attack, stroke, or of dying from cardiovascular disease. Participants, who on average had diabetes for 10 years at enrollment, were randomly assigned to either standard (5,123 participants) or intensive (5,128) blood sugar treatment goals. They were also enrolled in one of two other ACCORD randomized clinical trials examining effects of treatments for blood pressure or blood lipids; those study components will continue. Participants had been followed for 2 years to 7 years at the time the intensive blood sugar control t
'/>"/>

Contact: NHLBI Communications Office NHLBI_news@nhlbi.nih.gov 301-496-4236 NIH/National Heart, Lung and Blood Institute Source:Eurekalert

1 GOOD

Page: 1 2 3 4 5
Related medicine news :

1. Susan G. Komen for the Cure Sharing Grassroots Advocacy Knowledge With International Representatives in Intensive Dallas Training Session
2. Intensive training post-spinal cord injury can stimulate repair in brain and spinal cord
3. Intensive care quality of sleep improved by new drug, reports study
4. Smoking Cessation Rates Double With Intensive Counseling and Free Nicotine Replacement Therapy, Studies of 20,000 Smokers Show
5. Browns Wives Host Special Day at MetroHealth Medical Center to Support the Neonatal Intensive Care Unit
6. Large intensive care study reveals vital recommendations for treatment of brain injury patients
7. Dangerous Condition Underscores Importance of Home Blood Pressure Monitoring
8. Cord Blood America Supports Trend From New York, California for States to Inform Parents of the Advantages of Umbilical Cord Blood Storage
9. Novel small molecule therapy shows benefit for anemic patients via hydration of red blood cells
10. Research shows a daily does of beetroot juice can beat high blood pressure
11. Hospital Patients Blood Clot Risk High